- Clone
- A19034C (See other available formats)
- Regulatory Status
- RUO
- Other Names
- CD27 ligand, CD70, Ki-24 antigen, TNFSF7
- Isotype
- Rat IgG2a, κ
-
Recombinant mouse CD27L (CD70) (Cat. No. 550406) (black circles) binds to immobilized recombinant mouse CD27 (TNFRSF7)-Fc chimera (Cat. No. 765604). Ultra-LEAF™ Purified anti-mouse CD70 antibody (clone A19034C) (purple squares) inhibits the binding in a dose-dependent manner whereas the GoInVivo™ purified rat IgG2a, κ isotype ctrl antibody (Cat. No. 400562) (gray triangles) does not have the effect. This antibody blocks the binding of 0.14 µg/mL of recombinant mouse CD27L (CD70) to 2 µg/mL of immobilized recombinant mouse CD27 (TNFRSF7)-Fc chimera with an ND50 = 0.3 – 1.5 µg/mL.
| Cat # | Size | Price | Quantity Check Availability | ||
|---|---|---|---|---|---|
| 160801 | 100 µg | $171.00 | |||
| 160802 | 1 mg | $710.00 | |||
Select size of product is eligible for a 40% discount! Promotion valid until December 31, 2024. Exclusions apply. To view full promotion terms and conditions or to contact your local BioLegend representative to receive a quote, visit our webpage.
CD70, or CD27L, is a 50 kD type II transmembrane glycoprotein and member of the tumor necrosis factor superfamily. Mouse CD27L and its human counterpart share about 56% amino acid sequence identity. The interaction between CD27L and CD27, a protein of the TNF receptor superfamily expressed on NK cells and subsets of T and B cells, provides costimulatory signals that are required for T cell proliferation, clonal expansion, and promotion of effector T cell formation. CD27L-CD27 interaction on mouse B cells on the other hand, has been shown to inhibit terminal differentiation of B cells into plasma cells. CD27L expression is induced by antigen receptor activation in B cells and at low levels in mouse T cells. CD27 interaction with recombinant soluble CD27L protein (sCD27L), has shown that sCD27L enhances IFN-γ secretion by CD56 (bright) NK cells in the presence of IL-12, and these NK cells were able to suppress HCV replication. Also, CD8+ T cells stimulated with sCD27L in the presence of Ag showed enhanced proliferation and production of IL-2 and IFN-γ in vitro. In addition, administration of Ag and soluble CD27L induces expansion of Ag-specific CD8+ T cells in vivo. Data suggests that sCD27L is a potent stimulator of antiglioma immune responses that depend on CD8+ T cells; therefore, sCD27L might be an adjuvant for future immunotherapy trials for glioblastoma.
Product Details
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Recombinant mouse CD70
- Formulation
- 0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative.
- Preparation
- The Ultra-LEAF™ (Low Endotoxin, Azide-Free) antibody was purified by affinity chromatography.
- Concentration
- The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL. Older lots may have also been bottled at 1 mg/mL. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C. This Ultra-LEAF™ solution contains no preservative; handle under aseptic conditions.
- Application
-
Block - Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by blocking the binding between mouse CD27 (TNFRSF7) and mouse CD27L (CD70). The ND50 range: 0.3 – 1.5 µg/mL. It is recommended that the reagent be titrated for optimal performance for each application
- RRID
-
AB_2890724 (BioLegend Cat. No. 160801)
AB_2890724 (BioLegend Cat. No. 160802)
Antigen Details
- Structure
- Homodimer
- Distribution
-
Activated T cells, B cells, NK cells, antigen presenting cells, activated plasmacytoid dendritic cells (pDCs), chronic B cell lymphocytic leukemia, and large B cell lymphomas.
- Function
- Role in T cell proliferation, generation of cytolytic and memory T cells, B cell proliferation and differentiation. CD27L is induced by antigen receptor activation in B cells and downregulated by interaction with its receptor CD27.
- Interaction
- T cells, B cells, NK cells.
- Ligand/Receptor
- CD27
- Cell Type
- B cells, NK cells, T cells, Thymocytes
- Biology Area
- Cancer Biomarkers, Cell Proliferation and Viability, Immunology
- Molecular Family
- Cytokines/Chemokines, Growth Factors, Immune Checkpoint Receptors, Soluble Receptors
- Antigen References
-
- Bowman MR, et al. 1994. J Immunol. 152:1756-61.
- Shaw J, et al. 2010. Blood. 115:3051-7.
- Keller AM, et al. 2009. Blood. 113:5167-75.
- Tesselaar K, et al. 1997. J Immunol. 159:4959-65.
- Akiba H, et al. 1999. J Immunol. 162:7058-66.
- Miller J, et al. 2010. J Neurosurg. 113:280-5.
- Kuka M, et al. 2013. J Immunol. 191:2282-9.
- Jang YS, et al. 2013. Clin Immunol. 149:379-87.
- Gene ID
- 21948 View all products for this Gene ID
- UniProt
- View information about CD70 on UniProt.org
Other Formats
View All CD70 Reagents Request Custom Conjugation| Description | Clone | Applications |
|---|---|---|
| Ultra-LEAF™ Purified anti-mouse CD70 | A19034C | Block |
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
-
Ultra-LEAF™ Purified anti-mouse CD70
Recombinant mouse CD27L (CD70) (Cat. No. 550406) (black circ...